Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pituitary tumors and hyperprolactinemia.

W B Malarkey, J C Johnson

    Archives of Internal Medicine
    |January 1, 1976
    PubMed
    Summary

    Elevated prolactin levels were common in patients with pituitary tumors, even without acromegaly or Cushing syndrome. Monitoring prolactin may help track pituitary tumor growth and treatment effectiveness.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Symposium on Pellagra.

    Buffalo medical journal·2023
    Same author

    Some Observations on Gastric and Duodenal Ulcer.

    Buffalo medical journal·2023
    Same author

    Antikamnia.

    The Southern medical record·2022
    Same author

    The Real and Relative Value of Our Recent Antipyretics.

    Atlanta medical and surgical journal (1884)·2022
    Same author

    Perinatal fluoxetine exposure results in social deficits and reduced monoamine oxidase gene expression in mice.

    Brain research·2019
    Same author

    Incidence of variations in human cadaveric renal vessels.

    Folia morphologica·2017

    Area of Science:

    • Endocrinology
    • Neuroscience
    • Oncology

    Background:

    • Pituitary tumors can cause hormonal imbalances.
    • Hyperprolactinemia is a condition of elevated prolactin levels.
    • Clinical presentation of pituitary tumors varies.

    Purpose of the Study:

    • To investigate prolactin secretion in patients with pituitary tumors.
    • To correlate prolactin levels with tumor size and clinical symptoms.
    • To assess the utility of prolactin measurements in managing pituitary tumors.

    Main Methods:

    • Collected hourly blood samples over 24 hours from nine patients with pituitary tumors.
    • Measured serum prolactin and growth hormone levels.
    • Utilized pneumoencephalography to assess pituitary tumor size.
    • Monitored prolactin levels in two patients post-treatment.

    Main Results:

    • Eight of nine patients exhibited hyperprolactinemia.
    • Elevated prolactin levels were observed without significant growth hormone elevation.
    • Prolactin secretion showed blunted diurnal variation.
    • Higher prolactin concentrations correlated with larger pituitary tumors.
    • Decreased prolactin levels post-treatment corresponded with clinical improvement.

    Conclusions:

    • Hyperprolactinemia is a frequent finding in pituitary tumors, independent of acromegaly or Cushing syndrome.
    • Serum prolactin levels may serve as a valuable biomarker for pituitary tumor burden and therapeutic response.
    • Further research is warranted to establish prolactin monitoring in pituitary tumor management.

    Related Experiment Videos